Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644277 · ClinicalTrials.gov registry record · NA
A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury
A NA study of Spinal Cord Injuries, sponsored by Shirley Ryan AbilityLab.
- Active
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 3
- Study locations
NCT03644277: Active NA study of Spinal Cord Injuries, sponsored by Shirley Ryan AbilityLab.
NCT03644277 is a NA study of Spinal Cord Injuries that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 121 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (98% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03644277, a NA study of Spinal Cord Injuries, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall objective of this project is to investigate the effectiveness of daily acute intermittent hypoxia therapy (dAIH), coupled with massed practice training, to improve upper-extremity function in individuals with chronic incomplete cervical SCI.
Primary Outcome
The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) is an extensive and validated impairment and functional measure which is able to detect subtle neurologic changes in individuals with spinal cord injury. Specifically, it evaluates the domains of sensation, strength, quality of different grip patterns and the ability to complete a variety of functional tasks.
Conditions Studied
Interventions
- OTHER Acute Intermitted Hypoxia
- PROCEDURE Massed Practise
- OTHER Rapael Glove
Study Locations (3)
Illinois
- Edward Hines, Jr. VA Hospital - Chicago
- Shirley Ryan AbilityLab - Chicago
New Jersey
- Kessler Foundation - East Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT03644277 still lists
NCT03644277 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (98% higher).
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Acute Intermitted Hypoxia is the first listed.
NCT03644277 reports a single indexed study location in Illinois, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03644277 about?
NCT03644277 is a clinical study titled "A Multi-Center Clinical Trial in Individuals With Spinal Cord Injury". The overall objective of this project is to investigate the effectiveness of daily acute intermittent hypoxia therapy (dAIH), coupled with massed practice training, to improve upper-extremity function in individuals with chronic incomplete cervical SCI.
What is the current status of trial NCT03644277?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 121 participants. The study started on 2018-07-01. Estimated completion is 2026-07-01.
What conditions does trial NCT03644277 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT03644277?
The interventions under investigation include: Acute Intermitted Hypoxia (OTHER), Massed Practise (PROCEDURE), Rapael Glove (OTHER).
Who is sponsoring clinical trial NCT03644277?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644277 being conducted?
This trial has 3 study locations across Illinois, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03644277's enrollment target sits among peer trials
121 24th of 202 higher than 179 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy